Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

152.27
BATS BZX Real-Time Price
As of 1:08pm ET
 -2.36 / -1.53%
Today’s Change
71.46
Today|||52-Week Range
167.86
+106.69%
Year-to-Date
Is Gilead (GILD) Poised for a Beat This Earnings Season?
10:41am / Zacks.com - Paid Partner Content
What's in the Cards for Novartis (NVS) This Earnings Season?
Oct 18 / Zacks.com - Paid Partner Content
ETFs & Stocks Gaining from S&P 500's Record Run
Oct 20 / Zacks.com - Paid Partner Content
Innovative Pipelines & Regulatory Catalysts to Drive Pharma Stocks
Oct 17 / Zacks.com - Paid Partner Content
Is a Beat in the Cards for Vertex (VRTX) in Q3 Earnings?
Oct 20 / Zacks.com - Paid Partner Content
5 Health Care Companies in Gurus' Portfolios
Oct 16 / GuruFocus News - Paid Partner Content
4 of the Most Efficient Stocks to Buy Now
Oct 20 / Zacks.com - Paid Partner Content
5 Health Care Companies in Gurus' Portfolios
Oct 16 / GuruFocus News - Paid Partner Content
Zacks Industry Outlook Highlights: Novo, Vertex Pharmaceuticals, Celgene and Ligand P...
Oct 18 / Zacks.com - Paid Partner Content
Will Quest Diagnostics (DGX) Disappoint in Q3 Earnings?
Oct 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close154.63
Today’s open154.73
Day’s range152.19 - 155.02
Volume46,126
Average volume (3 months)1,760,539
Market cap$39.0B
Dividend yield--
Data as of 1:08pm ET, 10/23/2017

Growth & Valuation

Earnings growth (last year)+80.09%
Earnings growth (this year)+99.17%
Earnings growth (next 5 years)+68.00%
Revenue growth (last year)+64.89%
P/E ratio148.1
Price/Sales10.59
Price/Book33.20

Competitors

 Today’s
change
Today’s
% change
SHPGShire+0.53+0.36%
BAXBaxter International...+0.92+1.45%
ALXNAlexion Pharmaceutic...-3.05-2.19%
ZTSZoetis Inc-0.15-0.23%
Data as of 1:08pm ET, 10/23/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$0.36
Annual revenue (last year)$1.7B
Annual profit (last year)-$112.1M
Net profit margin-6.58%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jeffrey M. Leiden
Chief Operating Officer &
Executive Vice President
Ian F. Smith
Corporate headquarters
Boston, Massachusetts

Forecasts